Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Elizabeth Yeu-Lin, Hawaiian Eye 2021: Optimizing Refractive Outcomes with Toric Intraocular Lenses

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: May 21st 2021

As always, it was a pleasure to catch up with our esteemed Editor-in-Chief, Elizabeth Yeu-Lin (Eastern Virginia Medical School, Norfolk, VA, USA) to discuss her views on optimizing refractive outcomes with toric intraocular lenses (IOLs) and the patients who are most at risk for postoperative toric IOL surprises.

Question

  1. What factors are key to optimizing refractive outcomes with toric intraocular lenses (IOLs), which patients are most at risk for postoperative toric IOL surprises, and how can these risks be minimized? (00:18)

Speaker Disclosure: Elizabeth Yeu-Lin has no financial or non-financial relationships or activities to declare in relation to this interview.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Helen Fowler.

Filmed in coverage of Hawaiian Eye and Retina 2021.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup